PI3K-δ inhibition using CAL-101 exerts apoptotic effects and increases doxorubicin-induced cell death in pre-B-acute lymphoblastic leukemia cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PI3K-δ inhibition using CAL-101 exerts apoptotic effects and increases doxorubicin-induced cell death in pre-B-acute lymphoblastic leukemia cells

Published:2017-04 Issue:4 Volume:28 Page:436-445
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Safaroghli-Azar Ava,Bashash Davood,Sadreazami Parisa,Momeny Majid,Ghaffari Seyed H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference36 articles.

1. Advances in the molecular pathobiology of B-lymphoblastic leukemia;Zhou;Hum Pathol,2012

2. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment;Holleman;N Engl J Med,2004

3. Acute lymphoblastic leukaemia in elderly patients;Robak;Drugs Aging,2004

4. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood;Van Dongen;Lancet,1998

5. Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies;Barrett;Pediatr Drugs,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The PI3K signaling pathway; from normal lymphopoiesis to lymphoid malignancies;Expert Review of Anticancer Therapy;2024-05-08

2. In Vitro Biological Activity and Lymphoma Cell Growth Inhibition by Selected Mexican Medicinal Plants;Life;2023-04-06

3. Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells;International Journal of Molecular Sciences;2023-01-10

4. In the Pipeline—Emerging Therapy for ALL;Pathogenesis and Treatment of Leukemia;2023

5. Synergistic effects of PI3K inhibition and pioglitazone against acute promyelocytic leukemia cells;Molecular Genetics & Genomic Medicine;2022-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3